Find Trifarotene manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 895542-09-3, Cd5789, Cd-5789, 0j8rn2w0hk, 4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid, 3''-(tert-butyl)-4'-(2-hydroxyethoxy)-4''-(pyrrolidin-1-yl)-[1,1':3',1''-terphenyl]-4-carboxylic acid
Molecular Formula
C29H33NO4
Molecular Weight
459.6  g/mol
InChI Key
MFBCDACCJCDGBA-UHFFFAOYSA-N
FDA UNII
0J8RN2W0HK

Trifarotene
Trifarotene is a selective retinoic acid receptor gamma (RAR gamma) agonist that can be used in the treatment of acne vulgaris. Upon topical application, trifarotene selectively binds to the RAR gamma receptor, thereby altering the expression of certain genes that are involved in inflammation and cellular differentiation.
1 2D Structure

Trifarotene

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid
2.1.2 InChI
InChI=1S/C29H33NO4/c1-29(2,3)25-19-23(10-12-26(25)30-14-4-5-15-30)24-18-22(11-13-27(24)34-17-16-31)20-6-8-21(9-7-20)28(32)33/h6-13,18-19,31H,4-5,14-17H2,1-3H3,(H,32,33)
2.1.3 InChI Key
MFBCDACCJCDGBA-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)(C)C1=C(C=CC(=C1)C2=C(C=CC(=C2)C3=CC=C(C=C3)C(=O)O)OCCO)N4CCCC4
2.2 Other Identifiers
2.2.1 UNII
0J8RN2W0HK
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Aklief

2. Cd5789

2.3.2 Depositor-Supplied Synonyms

1. 895542-09-3

2. Cd5789

3. Cd-5789

4. 0j8rn2w0hk

5. 4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic Acid

6. 3''-(tert-butyl)-4'-(2-hydroxyethoxy)-4''-(pyrrolidin-1-yl)-[1,1':3',1''-terphenyl]-4-carboxylic Acid

7. 3''-tert-butyl-4'-(2-hydroxyethoxy)-4''-(pyrrolidin-1-yl)(1,1':3',1'')terphenyl-4-carboxylic Acid

8. Aklief

9. Trifarotene [inn]

10. Trifarotene [usan:inn]

11. Unii-0j8rn2w0hk

12. (1,1':3',1''-terphenyl)-4-carboxylic Acid, 3''-(1,1-dimethylethyl)-4'-(2-hydroxyethoxy)-4''-(1-pyrrolidinyl)-

13. [1,1':3',1''-terphenyl]-4-carboxylic Acid, 3''-(1,1-dimethylethyl)-4'-(2-hydroxyethoxy)-4''-(1-pyrrolidinyl)-

14. Aklief (tn)

15. Cd 5789

16. Trifarotene [mi]

17. Trifarotene (usan/inn)

18. Trifarotene [usan]

19. Trifarotene [who-dd]

20. Schembl381493

21. Gtpl9962

22. Chembl3707313

23. Dtxsid30237781

24. Trifarotene [orange Book]

25. Bcp31392

26. Ex-a2704

27. Bdbm50457548

28. Akos037649283

29. At10456

30. Db12808

31. Compound 15b [pmid: 29706423]

32. Bs-17812

33. Bt166038

34. Hy-100256

35. Cs-0018407

36. D11225

37. Cd5789; Cd-5789; Cd 5789

38. Q27236856

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 459.6 g/mol
Molecular Formula C29H33NO4
XLogP36.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count8
Exact Mass459.24095853 g/mol
Monoisotopic Mass459.24095853 g/mol
Topological Polar Surface Area70 Ų
Heavy Atom Count34
Formal Charge0
Complexity647
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Trifarotene is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.


Treatment of ichthyoses


Treatment of acne


5 Pharmacology and Biochemistry
5.1 Pharmacology

Trifarotene exerts its effects via agonism at retinoid receptors - these receptors function to alter DNA transcription, resulting in downstream modulation of the expression of various genes involved in acne pathogenesis. It may be associated with skin irritation and should not be applied to cuts, abrasions, or otherwise damaged skin. As trifarotene may result in photosensitivity, patients should be cautioned to avoid excess sun exposure and to use sunscreen and/or protective clothing if exposure is unavoidable.


5.2 MeSH Pharmacological Classification

Dermatologic Agents

Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)


5.3 ATC Code

D - Dermatologicals

D10 - Anti-acne preparations

D10A - Anti-acne preparations for topical use

D10AD - Retinoids for topical use in acne

D10AD06 - Trifarotene


5.4 Absorption, Distribution and Excretion

Absorption

Systemic absorption of trifarotene is minimal. In a pharmacokinetic study involving 19 subjects, systemic concentrations were only quantifiable in 7 - steady state Cmax values ranged from undetectable (<5 pg/mL) to 10 pg/mL and AUC0-24h ranged from 75 to 104 pg.h/mL.


Route of Elimination

Trifarotene is eliminated primarily in the feces.


5.5 Metabolism/Metabolites

Trifarotene is rapidly metabolized in human hepatocytes - its observed half-life in human keratinocytes is >24 hours, whereas half-life in human liver microsomes is approximately 5 minutes. Metabolism of trifarotene is catalyzed primarily by CYP2C9, CYP3A4, CYP2C8, and, to a lesser extent, CYP2B6.


5.6 Biological Half-Life

The terminal half-life of trifarotene is typically between 2 to 9 hours.


5.7 Mechanism of Action

Trifarotene is a potent and selective agonist of retinoic acid receptor- (RAR-). It has significantly less activity at RAR- and RAR- (16- and 65-fold lower than activity at RAR-, respectively), and has no activity at retinoid X receptors (RXRs). Agonism at retinoic acid receptors results in dimerization, and the resulting receptor-ligand dimer binds to specific DNA regulatory sequences (retinoic acid response elements, or RAREs) in the promotor regions of retinoid-responsible genes. Downstream alterations to gene expression induced by binding to these regions is the principle mechanism through which trifarotene exerts its comedolytic, anti-inflammatory, and depigmenting effects. Like other retinoids, trifarotene influences the expression of a number of genes involved in retinoid metabolism, epidermal differentiation/proliferation, and epidermal response to stress. In addition, trifarotene appears to modulate retinoid-mediated pathways involved in proteolysis, skin hydration, and cell adhesion - modulation of these additional pathways has not been observed with other retinoids and may therefore be unique to trifarotene.


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Trifarotene Manufacturers

A Trifarotene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trifarotene, including repackagers and relabelers. The FDA regulates Trifarotene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trifarotene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Trifarotene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Trifarotene Suppliers

A Trifarotene supplier is an individual or a company that provides Trifarotene active pharmaceutical ingredient (API) or Trifarotene finished formulations upon request. The Trifarotene suppliers may include Trifarotene API manufacturers, exporters, distributors and traders.

click here to find a list of Trifarotene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Trifarotene USDMF

A Trifarotene DMF (Drug Master File) is a document detailing the whole manufacturing process of Trifarotene active pharmaceutical ingredient (API) in detail. Different forms of Trifarotene DMFs exist exist since differing nations have different regulations, such as Trifarotene USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Trifarotene DMF submitted to regulatory agencies in the US is known as a USDMF. Trifarotene USDMF includes data on Trifarotene's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trifarotene USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Trifarotene suppliers with USDMF on PharmaCompass.

Trifarotene NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trifarotene as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Trifarotene API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Trifarotene as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Trifarotene and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trifarotene NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Trifarotene suppliers with NDC on PharmaCompass.

Trifarotene GMP

Trifarotene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Trifarotene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trifarotene GMP manufacturer or Trifarotene GMP API supplier for your needs.

Trifarotene CoA

A Trifarotene CoA (Certificate of Analysis) is a formal document that attests to Trifarotene's compliance with Trifarotene specifications and serves as a tool for batch-level quality control.

Trifarotene CoA mostly includes findings from lab analyses of a specific batch. For each Trifarotene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Trifarotene may be tested according to a variety of international standards, such as European Pharmacopoeia (Trifarotene EP), Trifarotene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trifarotene USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty